-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The purpose of this study was to assess the prevalence, type and association between the presence of autonobodies and the progression of neuropathy in patients with primary dryness syndrome (
pSS)conducted a comprehensive neuroandaphysiological examination of61patients withpSS, as well asimmune, including rheumatology factors (
RF) and autoimmune antibodies such as antinuclear antibodies (
ANA), anti-
-ro/SSa, and anti-
La/SSB antibodies 39 patients (
63.9 %) experienced axon loss or demyelination 29 subjects (
47.5 %) met the clinical and electrophysiological criteria for axon-based peripheral neuropathy In patients with normal neuroconduction studies, serum resistance to and anti-
-La antibodies are more common at the same time Most patients with axonal neuropathy are only positive for anti-
-Ro (
p 0.05 ) The presence of RF is associated with several electro-
diagnostic signs of demyelinating (
p 0.01 ) ANA titer display is not independently associated with neuropathy peripheral neuropathy is a common complication of primary dryness syndrome Compared to anti-
-Ro and anti-
La antibodies at the same time, only anti-
-Ro serological lygo were associated with an increased risk of axial neuropathy RF positive may lead to demyelination